SEC Form 5

FORM 5		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0362 Estimated average burden hours per response: 1.0
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
	Form 3 Holdings Reported.
	Form 4 Transactions Reported.
X	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person* Desmond Adam (Last) (First) (Middle) C/O 600 17TH ST., STE. 2800 SOUTH (Street) DENVER, COLORADO 80202 (City) (State) (Zip) UNITED STATES (Country)	2. Issuer Name and Ticker or Trading Symbol SELECTIS HEALTH, INC. [ GBCS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) CEO
	2a. Foreign Trading Symbol
	3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year) 12/31/2025	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
	4. If Amendment, Date of Original Filed (Month/Day/Year) 03/12/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Stock							38,434	D
Common Stock	02/20/2025		P	2,500	A	$1.5	40,934	D
Common Stock	02/24/2025		P	1,000	A	$2.05	41,934	D
Common Stock	03/05/2025		P	900	A	$2.25	42,834	D
Common Stock	03/14/2025		P	6	A	$2.08	42,840	D
Common Stock	03/20/2025		P	5	A	$2.08	42,845	D
Common Stock	03/24/2025		P	100	A	$2.15	42,945	D
Common Stock	05/01/2025		P	815	A	$2.06	43,760	D
Common Stock	05/01/2025		P	425	A	$2.03	44,185	D
Common Stock	05/15/2025		P	10	A	$1.5	44,195	D
Common Stock	05/28/2025		P	2	A	$1.6	44,197	D
Common Stock	06/03/2025		P	47	A	$1.25	44,244	D
Common Stock	06/09/2025		P	730	A	$1.6	44,974	D
Common Stock	06/11/2025		P	500	A	$1.81	45,474	D
Common Stock	06/11/2025		P	70	A	$1.61	45,544	D
Common Stock	06/12/2025		P	360	A	$1.61	45,904	D
Common Stock	07/15/2025		P	161	A	$2.44	46,065	D
Common Stock	08/01/2025		P	619	A	$2.4	46,684	D
Common Stock	10/06/2025		P	700	A	$2.1	47,384	D
Common Stock	10/09/2025		P	240	A	$1.74	47,624	D
Common Stock	10/17/2025		P	2,800	A	$1.75	50,424	D
Common Stock	12/19/2025		P	1,345	A	$2.2	51,769	D
Common Stock	12/31/2025		P	1,300	A	$2.25	53,069	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Warrant	$2.25	01/01/2026		A	12,500		01/01/2026	12/31/2027	Common Stock	12,500	$2.25	12,500	D

Explanation of Responses:

	/s/ Adam Desmond	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 5: SEC 2770T (03-26)